OpenAI forecasts over $20 billion revenue this year, planning $1.4 trillion data center investment over eight years to fuel ambitious growth targets.
Tesla FSD is expected to receive full approval in China by early 2026, making it the first foreign brand to commercialize full self-driving, solidifying its market position.
Pfizer acquires obesity drug developer Metsera for $10 billion, ending a bidding war with Novo Nordisk to enter the fast-growing weight-loss drug market.
Six AI pioneers discussed AGI in London, signaling its emergence in reality; Jensen Huang noted AGI is gradual, not sudden.
Nvidia releases and open-sources OmniVinci, a 9-billion-parameter full-modality large model capable of understanding video, audio, image, and text information simultaneously, with excellent performance.
Moonshot AI launches Kimi K2 Thinking inference framework, enhancing large models' step-by-step reasoning and self-correction, supporting ultra-long context processing.
Richard Liu predicts the AI and robotics era will lead to one-day workweeks, fully automated logistics, and a significant reduction in logistics costs.
Driven by the AI boom, global DRAM prices soared to record highs, with Q3 contract prices up 171.8% year-on-year, and shortages expected to continue.
Tesla shareholders failed to approve a proposal for the company to invest in Elon Musk's xAI, despite more votes in favor than against.
Microsoft apologized and offered refunds to millions of Australian users for over-promoting Copilot plans, facing a regulatory investigation.